REGENERON PHARMACEUTICALS, INC. (REGN) Gross profit 2016–2020
REGENERON PHARMACEUTICALS, INC. (REGN) annual gross profit history from SEC filings — each fiscal year as reported.
$8.1BFY2020 · since FY2016: $4.6B → $8.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $8.1B | +28.1% |
| FY2019 | $6.3B | +27.9% |
| FY2018 | $4.9B | -12.9% |
| FY2017 | $5.7B | +22.9% |
| FY2016 | $4.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More REGN financial trends
REGN RevenueREGN Net incomeREGN Net marginREGN Gross marginREGN Operating incomeREGN Operating marginREGN Operating cash flowREGN Free cash flowREGN Capital expendituresREGN Return on equityREGN Stock buybacksREGN Dividends paidREGN Total assetsREGN Total liabilitiesREGN Shareholders’ equityREGN overview →